Novel 2-hydrazino-pyrimidin-4(3H)-one derivatives as potential dihydrofolate reductase inhibitors
β Scribed by Mariam S. Degani; Seema Bag; Ranjeet Bairwa; Nilesh R. Tawari; Sherry F. Queener
- Book ID
- 102342041
- Publisher
- Journal of Heterocyclic Chemistry
- Year
- 2010
- Tongue
- English
- Weight
- 101 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0022-152X
- DOI
- 10.1002/jhet.216
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
magnified image
Novel substituted 2βhydrazinoβpyrimidinβ4(3__H__)βone derivatives were synthesized and examined for their antifolate activity against DHFR from Pneumocystis carinii (pc), Toxoplasma gondii (tg), Mycobacterium avium (ma), and rat liver (rl). A novel, simple, and feasible methodology was developed for the synthesis of the titled compounds. Amongst these, compound 8 6βphenylβ2β(2β(1β(thiophenβ2βyl) ethylidene)hydrazinyl) pyrimidinβ4(3__H__)βone exhibited 17.74 ΞΌ__M__ activity against pcDHFR. J. Heterocyclic Chem., (2010).
π SIMILAR VOLUMES
A series of seven nonclassical three carbon atom bridged 2,4-diamino-5-substituted-pyrrolo[2,3-d]pyrimidines 1a-g were synthesized as potential inhibitors of dihydrofolate reductase. Selective oxidation of diols 7a-g affords Ξ±-hydroxy ketones 8a-g. Subsequent condensation with malononitrile gave the